A Swedish-American Journey of Innovation in Cancer Research

Thanks! Share it with your friends!


A seminar focusing on the triple helix model, the Swedish Teachers’ Exemption, and how these frameworks spur academic innovation from the lab to bedside care.

The seminar took place on February 2, 2021 and was co-hosted by the Embassy of Sweden in Washington, DC, Dana-Farber Cancer Institute, Harvard Medical School, Uppsala University, and Oncopeptides AB.